A citation-based method for searching scientific literature

Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, Kristen Whitaker, Toshio F Yoshimatsu, Tom Walsh, David Schacht, Kirti Kulkarni, Deepa Sheth, Marion S Verp, Angela R Bradbury, Jane Churpek, Elias Obeid, Jeffrey Mueller, Galina Khramtsova, Fang Liu, Akila Raoul, Hongyuan Cao, Iris L Romero, Susan Hong, Robert Livingston, Nora Jaskowiak, Xiaoming Wang, Marcio Debiasi, Colin C Pritchard, Mary-Claire King, Gregory Karczmar, Gillian M Newstead, Dezheng Huo, Olufunmilayo I Olopade. Clin Cancer Res 2019
Times Cited: 27







List of co-cited articles
150 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
143
44

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
275
33

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
29

Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
Jan C M van Zelst, Roel D M Mus, Gwendolyn Woldringh, Matthieu J C M Rutten, Peter Bult, Suzan Vreemann, Mathijn de Jong, Nico Karssemeijer, Nicoline Hoogerbrugge, Ritse M Mann. Radiology 2017
43
29

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
706
29

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
29

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
334
25

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Sylvia K Plevritis, Allison W Kurian, Bronislava M Sigal, Bruce L Daniel, Debra M Ikeda, Frank E Stockdale, Alan M Garber. JAMA 2006
181
22

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
165
22

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
Inge-Marie Obdeijn, Gonneke A O Winter-Warnars, Ritse M Mann, Maartje J Hooning, M G Myriam Hunink, Madeleine M A Tilanus-Linthorst. Breast Cancer Res Treat 2014
39
22

Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
Glen Lo, Anabel M Scaranelo, Hana Aboras, Sandeep Ghai, Supriya Kulkarni, Rachel Fleming, Karina Bukhanov, Pavel Crystal. Radiology 2017
34
18

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
Christiane K Kuhl, Simone Schrading, Kevin Strobel, Hans H Schild, Ralf-Dieter Hilgers, Heribert B Bieling. J Clin Oncol 2014
302
18

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione,[...]. Invest Radiol 2011
197
18

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Julia Krammer, Katja Pinker-Domenig, Mark E Robson, Mithat Gönen, Blanca Bernard-Davila, Elizabeth A Morris, Debra A Mangino, Maxine S Jochelson. Breast Cancer Res Treat 2017
49
18

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel,[...]. Br J Cancer 2016
48
18

Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Janice S Sung, Sarah Stamler, Jennifer Brooks, Jennifer Kaplan, Tammy Huang, D David Dershaw, Carol H Lee, Elizabeth A Morris, Christopher E Comstock. Radiology 2016
67
18

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
773
18

Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Huong T Le-Petross, Gary J Whitman, Deanne P Atchley, Ying Yuan, Angelica Gutierrez-Barrera, Gabriel N Hortobagyi, Jennifer K Litton, Banu K Arun. Cancer 2011
50
18

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
237
18

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Sepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, Ritse M Mann, Diderick B W de Roy van Zuidewijn, Harmien M Zonderland, Rob A E M Tollenaar, Marc B I Lobbes, Margreet G E M Ausems, Martijne van 't Riet,[...]. Lancet Oncol 2019
55
18

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
656
14

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, Jan C Oosterwijk, Rob A Tollenaar, Gwendolyn H Woldringh, Elisabeth Bergers, Cornelis Verhoef, Eveline A Heijnsdijk, Maartje J Hooning,[...]. Int J Cancer 2015
53
14

MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J Massat, Anthony J Maxwell, Sarah Ingham, Rosalind Eeles, Martin O Leach,[...]. Breast Cancer Res Treat 2014
78
14

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Suzan Vreemann, Albert Gubern-Mérida, Margrethe S Schlooz-Vries, Peter Bult, Carla H van Gils, Nicoline Hoogerbrugge, Nico Karssemeijer, Ritse M Mann. Radiology 2018
27
14

Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Anna M Chiarelli, Kristina M Blackmore, Derek Muradali, Susan J Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea Eisen, Linda Rabeneck, Ellen Warner. J Natl Cancer Inst 2020
23
17


Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
537
14

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Bernadette A M Heemskerk-Gerritsen, Agnes Jager, Linetta B Koppert, A Inge-Marie Obdeijn, Margriet Collée, Hanne E J Meijers-Heijboer, Denise J Jenner, Hester S A Oldenburg, Klaartje van Engelen, Jakob de Vries,[...]. Breast Cancer Res Treat 2019
46
14

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
14

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
116
14

Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging.
Minh Thi Tieu, Candemir Cigsar, Sameera Ahmed, Andrea Ng, Lisa Diller, B-A Millar, Pavel Crystal, David C Hodgson. Cancer 2014
33
14

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Marije F Bakker, Stéphanie V de Lange, Ruud M Pijnappel, Ritse M Mann, Petra H M Peeters, Evelyn M Monninkhof, Marleen J Emaus, Claudette E Loo, Robertus H C Bisschops, Marc B I Lobbes,[...]. N Engl J Med 2019
181
14

The development of interval breast malignancies in patients with BRCA mutations.
Ian K Komenaka, Beth-Ann Ditkoff, Kathie-Ann Joseph, Donna Russo, Prakash Gorroochurn, Marie Ward, Elizabeth Horowitz, Mahmoud B El-Tamer, Freya R Schnabel. Cancer 2004
106
11

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
510
11

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
M J Stoutjesdijk, C Boetes, G J Jager, L Beex, P Bult, J H Hendriks, R J Laheij, L Massuger, L E van Die, T Wobbes,[...]. J Natl Cancer Inst 2001
227
11

Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers.
Kristin Bosse, Monika Graeser, Axel Goßmann, Matthias Hackenbroch, Rita K Schmutzler, Kerstin Rhiem. Arch Gynecol Obstet 2014
12
25

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
118
11

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
328
11

Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
Charu Taneja, John Edelsberg, Derek Weycker, Amy Guo, Gerry Oster, Jeffrey Weinreb. J Am Coll Radiol 2009
65
11

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
54
11

Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
Nariya Cho, Wonshik Han, Boo-Kyung Han, Min Sun Bae, Eun Sook Ko, Seok Jin Nam, Eun Young Chae, Jong Won Lee, Sung Hun Kim, Bong Joo Kang,[...]. JAMA Oncol 2017
65
11


Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
Reka Pataky, Linlea Armstrong, Stephen Chia, Andrew J Coldman, Charmaine Kim-Sing, Barbara McGillivray, Jenna Scott, Christine M Wilson, Stuart Peacock. BMC Cancer 2013
35
11

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.
Elisabeth Chéreau, Catherine Uzan, Corinne Balleyguier, Julie Chevalier, Brigitte Bressac de Paillerets, Olivier Caron, Françoise Rimareix, Marie-Christine Mathieu, Martin Koskas, Céline Bourgier,[...]. Clin Breast Cancer 2010
11
27

Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Christiane K Kuhl, Kevin Strobel, Heribert Bieling, Claudia Leutner, Hans H Schild, Simone Schrading. Radiology 2017
143
11

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Christiane K Kuhl, Simone Schrading, Heribert B Bieling, Eva Wardelmann, Claudia C Leutner, Roy Koenig, Walther Kuhn, Hans H Schild. Lancet 2007
434
11

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Sepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, Nicoline Hoogerbrugge, Jan C Oosterwijk, Rob A E M Tollenaar, Maartje Hooning, Claudette E Loo, Inge-Marie Obdeijn, Eveline A M Heijnsdijk,[...]. J Natl Cancer Inst 2013
47
11

Abbreviated MRI of the Breast: Does It Provide Value?
Doris Leithner, Linda Moy, Elizabeth A Morris, Maria A Marino, Thomas H Helbich, Katja Pinker. J Magn Reson Imaging 2019
38
11

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.
Xuan-Anh Phi, Nehmat Houssami, Maartje J Hooning, Christopher C Riedl, Martin O Leach, Francesco Sardanelli, Ellen Warner, Isabelle Trop, Sepideh Saadatmand, Madeleine M A Tilanus-Linthorst,[...]. Eur J Cancer 2017
14
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.